![]() Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Relay Therapeutics Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities. | ![]() InxMed InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines. | |
Founding Date | Founding Date 2010 | Founding Date 1996 | Founding Date 2016 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Needham, US HQ Walsrode, DE | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, US HQ | Locations HQ |
Employees | Employees 7328% increase | Employees 75,883 | Employees 2724% decrease | Employees 17 |
Valuation ($) | Valuation ($) 144.9 m | Valuation ($) N/A | Valuation ($) 958.5 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $15.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($209.5m) (FY, 2025) | Net income $14b (FY, 2025) | Net income ($276.5m) (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Phase I/II Trials Products | Phase I/II Trials Products 6 (FY, 2020) | Phase I/II Trials Products 100 (FY, 2022) | Phase I/II Trials Products N/A | Phase I/II Trials Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 170m | Total funding raised $ 6.5m | Total funding raised $ 520m | Total funding raised $ 19m |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
View company
InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines.
View company